Last reviewed · How we verify
NCT05089552
Quality of Life of Caregivers of Addicts
trial testing 1-WHOQOL-BREF(WHO-Quality of life-BREFF) Arabic version Scale in Addiction in 160 participants. Status unknown.
1 August 2023
Quick facts
| Lead sponsor | Assiut University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 160 |
| Start date | 1 January 2023 |
| Primary completion | 1 August 2023 |
| Estimated completion | 1 October 2023 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- 1-WHOQOL-BREF(WHO-Quality of life-BREFF) Arabic version Scale
- SCL-90-R(Symptoms Checklist-90-Revised) Arabic version scale
- addiction severity index
Conditions studied
- Addiction — all drugs for Addiction →
Sponsor
Assiut University
Who can join
18 and older, any sex, with Addiction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
American Society of Addiction Medicine defined Addiction as a treatable, chronic medical disease involving complex interactions among brain circuits, genetics, the environment, and an individual's life experiences. People with addiction use substances or engage in behaviors that become compulsive and often continue despite harmful consequences. Addiction is considered as a "family disease." Addiction affects the individual as well as those around them in terms of occupational and social dysfunction, physical and emotional distress, and financial burden which has a serious impact on the lives of the significant others.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05089552
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Addiction
Currently open trials in the same condition.
- NCT06618755 — Motivational Interviews Post Hospitalisation on Maintaining AbstiNence for 1 Year après le Sevrage en Alcool · NA · recruiting
- NCT06973512 — HABITS Study (Helping Addiction by Individualized Therapeutic Stimulation): Pilot Trial of Deep Brain Stimulation Guided · NA · recruiting
- NCT06264895 — Protocol for a Low Threshold Exercise Intervention for Women Experiencing Homelessness and Addiction. · NA · active not recruiting
- NCT06187766 — Effects of Social Media Addiction on Physical Activity Level and Exercise Capacity in University Students · active not recruiting
- NCT06015893 — Semaglutide Therapy for Alcohol Reduction (STAR) · Phase 2 · recruiting
Other Assiut University trials
Trials by the same sponsor.
- NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
- NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
- NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
- NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
- NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05089552 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assiut University
- Last refreshed: 3 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05089552.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing